p.96 抽出テキスト

damage in untreated hypertensive patients. J Hypertens 2009; 27: 712-720. PMID: 19516171 584. Hoshide S, Kubota K, Kario K. Difference between morning and evening blood pressure at home and nocturnal hypoxia in the general practitioner-based J-HOP study. Hypertens Res 2023; 46: 751-755. PMID: 36207529 585. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2021; 144: e56-e67. PMID: 34148375 586. Cowie MR, Linz D, Redline S, et al. Sleep Disordered Breathing and Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol 2021; 78: 608-624. PMID: 34353537 587. Kario K. Obstructive sleep apnea syndrome and hypertension: mechanism of the linkage and 24-h blood pressure control. Hypertens Res 2009; 32: 537-541. PMID: 19461649 588. Ishikawa J, Hoshide S, Eguchi K, et al. Increased low-grade inflammation and plasminogen-activator inhibitor- 1 level in nondippers with sleep apnea syndrome. J Hypertens 2008; 26: 1181-1187. PMID: 18475156 589. Kario K, Ikemoto T, Kuwabara M, et al. Catheter-Based Renal Denervation Reduces Hypoxia-Triggered Nocturnal Blood Pressure Peak in Obstructive Sleep Apnea Syndrome. J Clin Hypertens (Greenwich) 2016; 18: 707-709. PMID: 26718924 590. Tanaka M. Improving obesity and blood pressure. Hypertens Res 2020; 43: 79-89. PMID: 31649313 591. Sakiyama N, Tomooka K, Maruyama K, et al. Association of sleep-disordered breathing and alcohol consumption with hypertension among Japanese male bus drivers. Hypertens Res 2021; 44: 1168-1174. PMID: 34099883 592. Kario K, Nomura A, Harada N, et al. Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH 1 pivotal trial. Eur Heart J 2021; 42: 4111- 4122. PMID: 34455443 593. Norman D, Loredo JS, Nelesen RA, et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006; 47: 840- 845. PMID: 16585412 594. Fava C, Dorigoni S, Dalle Vedove F, et al. Effect of CPAP on blood pressure in patients with OSA/hypopnea: A systematic review and meta-analysis. Chest 2014; 145: 762-771. PMID: 24077181 595. Baguet JP, Barone-Rochette G, Pépin JL. Hypertension and obstructive sleep apnoea syndrome: current perspectives. J Hum Hypertens 2009; 23: 431-443. PMID: 19129854 596. Logan AG, Tkacova R, Perlikowski SM, et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003; 21: 241-247. PMID: 12608436 597. Martínez-García MA, Gómez-Aldaraví R, Soler-Cataluña JJ, et al. Positive effect of CPAP treatment on the control of difficult-totreat hypertension. Eur Respir J 2007; 29: 951- 957. PMID: 17301092 598. Akashiba T, Minemura H, Yamamoto H, et al. Nasal continuous positive airway pressure changes blood pressure “non-dippers” to “dippers” in patients with obstructive sleep apnea. Sleep 1999; 22: 849-853. PMID: 10566903 599. Robinson GV, Langford BA, Smith DM, et al. Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA). Thorax 2008; 63: 855-859. PMID: 18388204 600. Robinson GV, Smith DM, Langford BA, et al. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006; 27: 1229- 1235. PMID: 16455835 601. Barbé F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med 2001; 134: 1015-1023. PMID: 11388814 602. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68- 73. PMID: 12515745 603. Hoshide S, Yoshida T, Mizuno H, et al. Association of Night-to- Night Adherence of Continuous Positive Airway Pressure With Day-to-Day Morning Home Blood Pressure and Its Seasonal Variation in Obstructive Sleep Apnea. J Am Heart Assoc 2022; 11: e024865. PMID: 35322679 604. Iftikhar IH, Valentine CW, Bittencourt LR, et al. Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a meta-analysis. J Hypertens 2014; 32: 2341-2350. PMID: 25243523 605. Martinez-Garcia MA, Pengo MF. Clinical Phenotype of Resistant Hypertension Responders to Continuous Positive Airway Pressure Treatment: Results From the HIPARCO Randomized Clinical Trial. Hypertension 2021; 78: 559-561. PMID: 34148360 606. Lui MM, Tse HF, Lam DC, et al. Continuous positive airway pressure improves blood pressure and serum cardiovascular biomarkers in obstructive sleep apnoea and hypertension. Eur Respir J 2021; 58: 2003687. PMID: 33795324 607. Bartel PR, Loock M, Becker P, et al. Short-term antihypertensive medication does not exacerbate sleep-disordered breathing in newly diagnosed hypertensive patients. Am J Hypertens 1997; 10: 640-645. PMID: 9194510 608. Grote L, Wutkewicz K, Knaack L, et al. Association between blood pressure reduction with antihypertensive treatment and sleep apnea activity. Am J Hypertens 2000; 13: 1280- 1287. PMID: 11130772 609. Kraiczi H, Hedner J, Peker Y, et al. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000; 161: 1423- 1428. PMID: 10806134 610. Planès C, Foucher A, Leroy M, et al. Effect of celiprolol treatment in hypertensive patients with sleep apnea. Sleep 1999; 22: 507-513. PMID: 10389226 611. Buffolo F, Li Q, Monticone S, et al. Primary Aldosteronism and Obstructive Sleep Apnea: A Cross-Sectional Multi-Ethnic Study. Hypertension 2019; 74: 1532-1540. PMID: 31679423 612. Yang L, Zhang H, Cai M, et al. Effect of spironolactone on patients with resistant hypertension and obstructive sleep apnea. Clin Exp Hypertens 2016; 38: 464-468. PMID: 27367159 613. Bucca CB, Brussino L, Battisti A, et al. Diuretics in obstructive sleep apnea with diastolic heart failure. Chest 2 0 0 7 ; 1 3 2 : 440-446. PMID: 17699130 614. Cicolin A, Mangiardi L, Mutani R, et al. Angiotensin-converting enzyme inhibitors and obstructive sleep apnea. Mayo Clin Proc 2006; 81: 53-55. PMID: 16438479 615. Kario K, Okada K, Kato M, et al. 24-Hour Blood Pressure- Lowering Effect of an SGLT-2 Inhibitor in Patients with Diabetes and Uncontrolled Nocturnal Hypertension: Results from the Randomized, Placebo-Controlled SACRA Study. Circulation 2018; 139: 2089-2097. PMID: 30586745 616. Kario K, Ferdinand KC, O’Keefe JH. Control of 24-hour blood pressure with SGLT2 inhibitors to prevent cardiovascular disease. Prog Cardiovasc Dis 2020; 63: 249-262. PMID: 32275926 617. Kario K, Ferdinand KC, Vongpatanasin W. Are SGLT2 Inhibitors New Hypertension Drugs? Circulation 2021; 143: 1750- 1753. PMID: 33939525 618. Williams B, Cockcroft JR, Kario K, et al. Effects of Sacubitril/ Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study. Hypertension 2017; 69: 411-420. PMID: 28093466 619. Bavishi C, Messerli FH, Kadosh B, et al. Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials. Eur Heart J 2015; 36: 1967- 1973. PMID: 25898846 620. Kario K, Sun N, Chiang FT, et al. Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: A randomized, double-blind, placebo-controlled study. Hypertension 2014; 63: 698- 705. PMID: 24446062 621. Kario K, Weber M, Ferrannini E. Nocturnal hypertension in diabetes: Potential target of sodium/glucose cotransporter 2 (SGLT2) inhibition. J Clin Hypertens (Greenwich) 2018; 20: 424- 428. PMID: 29457344 622. Neeland IJ, Eliasson B, Kasai T, et al. EMPA-REG OUTCOME Investigators. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020; 43: 3007-3015. PMID: 33004464 623. Iftikhar IH, Hays ER, Iverson MA, et al. Effect of oral appliances on blood pressure in obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med 2013; 9: 165- 174. PMID: 23372472 624. Fehrm J, Friberg D, Bring J, et al. Blood pressure after modified uvulopalatopharyngoplasty: results from the SKUP 3 randomized controlled trial. Sleep Med 2017; 34: 156-161. PMID: 28522085 625. Warchol-Celinska E, Prejbisz A, Kadziela J, et al. Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea: Randomized Proof-of-Concept Phase II Trial. Hypertension 2018; 72: 381-390. PMID: 29941516